Trials / Completed
CompletedNCT04097808
Impact of the Source and Food Matrices on the Bioavailability of Peptan® (Collagen Peptides) in Healthy Subjects
Impact of the Source and Polyphenol-containing Food Matrices on the Bioavailability of Peptan® (Collagen Peptides) in Healthy Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Rousselot BVBA · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is the comparison of the oral bioavailability of hydroxyproline, a key marker for collagen peptide intake, after ingestion of collagen peptides from different sources, sizes and together with different food matrices, either containing high or low levels of polyphenols.
Detailed description
The absorption (blood) of collagen peptides from bovine, fish and porcine source in different sizes and administered together with foods of different polyphenol content will be assessed. Pharmacokinetic parameters (AUC0-6h, Cmax and Tmax) after oral single dose administration will be determined to estimate the impact of different sources, different peptide sized any food matrix. The following objectives will be evaluated exploratory by comparison of pharmacokinetic parameters from the concentration time curve of hydroxyproline, a key marker of collagen type I, between: * different sources of collagen peptides (bovine, fish, porcine) * different sizes of collagen peptides from cattle * food matrices impact on uptake of bovine collagen peptides (dissolved in water vs. food matrix 1 vs. food matrix 2). Additionally, concentration time curves of further amino acids will be assessed descriptively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | collagen peptides | Collagen peptides will be orally administered and pharmacokinetic parameters will be assessed up to 6 hours after study product intake. |
Timeline
- Start date
- 2019-09-20
- Primary completion
- 2019-10-25
- Completion
- 2019-10-25
- First posted
- 2019-09-20
- Last updated
- 2020-04-30
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04097808. Inclusion in this directory is not an endorsement.